European strategies for CBD to be addressed at summit
A three-tier approach to CBD regulation being advanced by the European Industrial Hemp Association (EIHA) will be reviewed during “The Future of Medical Hemp” micro-summit…
CBD
Lawsuit, media campaign hit Facebook over CBD, hemp ads
A U.S. company has filed suit in federal courts against Facebook for rejecting its advertising. Cannaramic Media, Inc. and its founder Felicia Palmer are taking…
Hemp shipments in USA should ease later this year
The movement of hemp and hemp-based products around the United States should be easier soon as a result of recent developments at the federal level….
Hemp leaders will address CBD summit set for late August
Cannabis veteran Steph Sherer of the International Cannabis and Cannabinoids Institute (ICCI) and other leading experts will address The Future of Medical Hemp Summit hosted…
U.S. researchers say synthetic CBD easier, faster, cheaper
American researchers in California say they have demonstrated that a new, far-less-expensive synthetic version of CBD can be as effective in treating certain maladies as…
‘All of a sudden, my 40,000 followers want to grow hemp’
INTERVIEW: American hemp legend Richard Rose recently released a treasure trove of reports, scientific papers and other documents about hemp online at The Richard Rose…
CBD research authorization is granted to Elixinol in New York
CBD maker Elixinol has been granted Processor Research Partner Authorization by the New York (U.S.) Department of Agriculture and Markets, which is actively supporting hemp…
$22m investment to start ‘CBD industrial park’ in China
Chinese hemp firm Shineco and the Xingshan People’s Government of Hegang City in Heilongjiang Province say they will actively promote the development of the hemp…
Hemp extracts are firm in EU history, EIHA paper shows
The European Industrial Hemp Association (EIHA) has published a collection of historical evidence documenting the consumption hemp food and hemp food extracts in Europe to…
Cost of exec’s retirement flagged in Q1 $9.4m loss by CV Sciences
U.S.-based CBD maker CV Sciences lost $9.4 million in the first quarter of 2019, the company said in a report issued May 8, 2019. The…